1.
Complic of empiric antibiotic use:
Resistance:
primary through conjugation via F
plasmid (also transduction (thru bacteriophage) and transformation (the great
vacuum cleaner); transposon = mobile genetic element which insert into phages,
plasmids, chromosomes w/o DNA homology è carry genes for resistance/virulence
Fungal
Infection: vaginitis (yeast
infect; Candida) when taking abx (also oral contraceptives, during
menses/pregnancy) è inflamed vaginal mucosa and patches of cottage
cheese-appearing white clumps affixed to vaginal wall; treat w/ imidazole
Pseudomembranous
colitis from C.difficle: kill
all normal colonic flora w/ abx (clindamycin and penicillin family drugs) and C. difficle can proliferate è secrete exotoxin è epithelial death and colonic ulcerations covered w/ exudative memb;
present w/ severe diarrhea; treat w/ oral vancomycin or metronidazole (neither absorbed by GI tract; therefore, highly
concentrated in the colon).
Question 2 - secondary effects of common drugs
I used coursepack notes, phi chi’s, my notes, micro made ridiculously simple, appleton and lange pharm. i also decided not to do the autonomic drugs, since i think that they are easier to learn as examples of the autonomic pharmacology, as opposed to isolated in a table. but if anyone wants me to do them , or if there are any questions/suggestions, please let me know.
|
drug |
secondary effects |
|
|
|
|
antiorganisms |
|
|
|
|
|
penicillin |
anaphalaxis |
|
cephalosporin |
bleeding (interferes with vit k clotting factors); disulfiram-like effect |
|
vancomycin |
ototoxicity; nephrotoxicity; red man syndrome (after rapid infusion) |
|
aminoglycosides |
vestibulotoxicity; ototoxicity; nephrotoxicity;curare-like effect |
|
tetracycline/doxycycline |
effects on bone (don’t give to kids under 8 or if pregnant);gi irritation; phototoxic dermatitis; renal, hepatic toxicity |
|
chloramphenicol |
gray baby syndrome; aplastic anemia |
|
macrolides (erythro-, clarithro-, azithromycin) |
inhibitor of p450; gi irritation; cholestatic hepatitis |
|
sulfonamides |
p450 interactions; displaces drugs from plasma proteins |
|
quinolones (-floxacin) |
don’t give to kids (tendon rupture, damage to growing cartilege) |
|
clindamycin |
pseudomembranous colitis (treat with metronidazole or vancomycin orally) |
|
metronidazole |
metallic taste |
|
amphotericin b |
nephrotoxic; anemia |
|
flucytosine |
bone marrow toxicity; elevated hepatic enzymes |
|
-azole antifungals |
hepatotoxic; gi toxic; p450 |
|
isoniazid |
peripheral neuritis; hepatotoxic |
|
rifampin |
red color to body fluids; p450 |
|
ethambutol |
vision loss |
|
ganciclovir |
bone marrow toxicity (neutropenia, thrombocytopenia) |
|
ribavirin |
very toxic (anemia, bone marrow toxicity); teratogenic, mutagenic—do not use in pregnant women |
|
foscarnet |
bone marrow toxicity,; nephrotoxic |
|
interferons |
flu-like syndrome; bone marrow toxicity; suicidal tendencies (CNS toxicity); p450 |
|
azt |
bone marrow toxicity (granulocytopenia, anemia) |
|
acyclovir |
nephrotoxic (prevented by giving adequate water) |
|
|
|
|
|
|
|
cancer drugs |
|
|
|
|
|
cyclophosphamide |
hemorrhagic cystitis; bone marrow ablation |
|
nitrosoureas |
bone marrow toxicity |
|
cisplatinum |
cisplatinum-renal toxicity; ototoxicity (don’t give with loop diuretics) |
|
methotrexate |
renal toxicity; myelosuppression; liver fibrosis; do not use if pregnant |
|
fluorouracil (5-fu) |
bone marrow toxicity; hand foot syndrome |
|
cytosine arabinoside (ara-c) + gemcitabine |
bone marrow toxicity |
|
6-mercaptopurine (6-mp) |
bone marrow toxicity; tumor lysis syndrome leads to hyperuricemia, give allopurinol to prevent |
|
vinca alkaloids |
vincristine-peripheral neuropathy vinblastine-myelosuppression |
|
paclitaxel |
hypersensitivity reactions; bone marrow toxicity |
|
doxorubicin (adriomycin) |
cardiomyopathy; red urine |
|
bleomycin |
pulmonary fibrosis; anaphylaxis |
|
|
|
|
|
|
|
heart drugs |
|
|
|
|
|
quinidine |
cinchonism (gi upset, tinnitus, visual disturbances, dizziness) |
|
procainamide |
lupus-like syndrome |
|
flecaininde, propafenone |
av block, ventricular fibrillation |
|
amiodarone |
pulmonary fibrosis; neuropathy; abn. epithelial pigmentation; hypothyroid; haloes around lights; blurred vision; corneal epithelial whorls; optic neuropathy |
|
lidocaine |
seizures |
|
disopyramide |
atropine-like side effects |
|
aspirin |
gi toxicity; ototoxicity |
|
adp receptor antagonists (ticlopidine, clopidogrel) |
neutropenia |
|
gp 2b/3a receptor antagonists |
|
|
nitroglycerin |
headache; flushing; dizziness; palpitations |
|
nifedipine |
reflex tachycardia |
|
statins |
myopathy (esp. if used with niacin or gemfibrozil) |
|
fibrates |
gemfibrozil-cholelithiasis; displaces other drugs from plasma proteins clofibrate-in men, gi and malignant disease |
|
niacin |
flushing, pruritis; don’t use if ulcers, gout, diabetes mellitus |
|
heparin |
osteoporosis |
|
warfarin |
bleeding; don’t use if pregnant (bone defects in fetus) |
|
ace inhibitors |
cough; angioedema; don’t use if pregnant |
|
prazosin |
orthostatic hypotension (first dose) |
|
clonidine |
use during pregnancy |
|
hydralazine |
peripheral neuritis |
|
nitroprusside |
cyanide poisoning |
|
digoxin |
signs of digoxin toxicity-colored vision; anorexia; nausea, vomiting; lethargy |
|
|
|
|
|
|
|
respiratory drugs |
|
|
|
|
|
leukotriene synthesis inhibitor (zileuton) |
p450; hepatotoxic |
|
theophylline |
seizures |
|
|
|
|
|
|
|
renal drugs |
|
|
|
|
|
thiazides |
gout; hyperlipidemia; hyperglycemia; hypercalcemia; sulfonamide cross-sensitivity |
|
loop diuretics |
hypochloremic alkalosis; ototoxicity |
|
spironolactone |
endocrine imbalances (gynecomastia, altered libido, impotence, hirsutism) |
|
cyclosporin a + tacrolimus |
nephrotoxic |
|
mycophenolate |
gi, hematopoietic toxicities |
|
sirolimus |
hyperlipidemia; hematopoietic toxicity |
|
okt3 |
pulmonary edema; high fevers |
|
|
|
|
|
|
|
derm drugs |
|
|
|
|
|
accutane (and other retinoids) |
dermatitis; hyperlipidemia; teratogen (do not take when pregnant); depression |
|
|
|
|
|
|
|
gi drugs |
|
|
|
|
|
h2-receptor antagonists (cimetidine…) |
p450; thrombocytopenia; endocrine (impotence, decreased sperm, gynecomastia) |
|
proton pump inhibitors (omeprazole…) |
p450 |
|
antacids |
aluminum-constipation; hypophosphotemia calcium-constipation magnesium-diarrhea |
|
sucralfate (aluminum salt) |
constipation; hypophosphotemia; neurotoxicity; bezoar formation |
|
misoprosol (prostaglandin analog) |
do not use if pregnant |
|
bismuth |
dark stools; use with caution if renal failure |
|
cisapride |
cardiac arrhythmias |
|
seratonin receptor antagonists (alosetron ) |
ischemic colitis; constipation |
|
|
|
|
|
|
|
neuro drugs |
|
|
|
|
|
narcotics side notes: dextromethorphan-cough suppressant etorphine-short acting, very potent apomorphine-induces vomiting (dopamine) |
respiratory depression; nausea, vomiting; miosis; release of anti-diuretic hormone; convulsions (esp. with meperidine, propoxyphene); constipation (diphenoxylate, loperimide used as anti-diarrheals); increased smooth muscle tone; hypotension |
|
esters (procaine) |
more allergenic than amides (lidocaine) |
|
phenytoin |
binds plasma proteins; p450; gingival hyperplasia; folate/vit k deficiency in newborns if given iv for status epilepticus-ph 12, irritating to veins, so fos-phenytoin used instead |
|
carbamazepine |
agranulocytosis; aplastic anemia; vit k deficiency in newborns |
|
phenobarbital |
p450; vit k deficiency in newborns |
|
valproic acid |
weight gain; alopecia; do not use if pregnant; thrombocytopenia; hepatotoxic |
|
felbamate |
aplastic anemia |
|
halothane |
arrhythmogenic; bronchodilator; malignant hyperthermia if used with succinylcholine; uterine relaxation; hepatotoxicity |
|
nitrous oxide |
long term exposure-vit b12 deficiency |
|
sedative-hypnotic drugs benzodiazepines, zolpidem barbiturates buspirone |
cognitive impairment; decreased psychomotor skills; daytime sedation; cns depression (but rare for buspirone); respiratory, cardio depression; barbiturates-induce liver enzymes, displaces other drugs from plasma proteins |
|
antipsychotics (p. 529 neuro coursepack) clozapine-almost no motor side effects, used to treat parkinson’s, high affinity for serotonin receptors |
side effects dependent on potency 1. increased potency means increased binding to dopamine d2 receptors, giving increased motor side effects 2. decreased potency means drug binds to lots of things, giving increased autonomic side effects |
|
tricyclic antidepressants (p.615 neuro coursepack) |
sedation, atropine like effects (tertiary>secondary amines); cardiovasc effects |
|
serotonin-selective reuptake inhibitors (fluoxetine) |
stimulant; nausea, diarrhea; weight loss |
|
moa inhibitors |
hypotension; don’t eat with tyramine foods; hepatotoxic |
|
mirtazapine |
agranulocytosis |
|
lithium |
nephropathy |
|
eye topical anesthetics |
don’t use chronically |
|
corticosteroids |
cataracts; glaucoma; makes infections worse if systemic, also get pseudotumor cerebri |
|
amiodarone (used for heart) |
haloes around lights; blurred vision; corneal epithelial whorls; optic neuropathy; pulmonary fibrosis; neuropathy; abn. epithelial pigmentation; hypothyroid |
|
anticholinergics |
loss of accomodation; blurred vision; pupillary dilation; angle-closure galucoma |
|
digoxin (used for heart) |
color vision defects |
|
hydroxychloroquine (used for lupus) |
retinal atrophy |
|
tamoxifen |
corneal whorls; crystalline retinopathy |
|
|
|
|
|
|
|
endocrine drugs |
|
|
|
|
|
sulfonylureas (glyburide) |
hypoglycemia; sulfa allergic reactions |
|
metformin |
appetite suppression; gi distress; lactic acidosis |
|
thiazolidinediones (-glitazones) |
liver failure; gi distress |
|
acarbose |
gi distress |
|
|
|
|
|
|
|
repro drugs |
|
|
|
|
|
oral contraception (p.79 repro coursepack) |
increased coagulability; breast cancer |
|
estrogen |
breast cancer |
|
progesterone |
increases cholesterol; mood changes |
|
triphenyethylenes |
stimulates endometrium, ovaries (but not breast) |
|
benzothiaphenes |
increased hot flashes |
|
|
|
|
|
|
|
musculoskeletal drugs |
|
|
|
|
|
nsaids |
gi, renal, liver; cns toxicity |
|
hydroxychloroquine |
retinal atrophy |
|
methotrexate |
renal toxicity; myelosuppression; liver fibrosis; do not use if pregnant |
|
cyclophosphamide |
hemorrhagic cystitis; bone marrow ablation |
|
allopurinol |
gi upset; peripheral neuritis; vasculitis |
|
|
|
|
|
|
|
|
|
|
corticosteroids |
adrenal suppression; metabolic effects (growth inhibition, diabetes, muscle wasting, osteoporosis); salt retention; psychosis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.
Fundamental Pharmacodynamics
|
Agonist |
drug that activates its R
upon bindg |
|
Effector |
component of bio sys that
accomplishes the bio effect after being activated by a R; channel/enz |
|
Pharmacologic Antagonist |
drug that binds to its R w/o
activating it |
|
Compet Antag |
can be overcome by
increasing the dose of agonist |
|
Irrev Antag |
cannot be overcome by
increasing dose of agonist |
|
Physio Antag |
drug that counters the
effects of another by binding to a different R and causing opposing effects |
|
Chem Antag |
counters effects of another
drug by binding it and blocking its actions |
|
Partial Agonist |
binds its R but produces a
smaller effect at full dosage than a full agonist |
|
Graded dose-response curve |
increasing responses to
increasing doses of drug |
|
Quantal dose-response curve |
a graph of the fraction of a
pop that shows a specified response to increasing doses of a drug |
|
EC50 |
·
in a graded
dose-response curve, the conc/dose that prod 50% of the max possible response ·
in a quantal dose
response curve, the dose that causes the specified response in 50% of the pop |
|
Kd |
conc of drug that results in
binding to 50% of R |
|
Therapeutic Index |
LD50/ED50; ratio of
lethal/effective dose |
|
Efficacy |
Max effect a drug can bring
about, regardless of dose; asymptote of curve |
|
Potency |
dose/conc req to bring about
50% of drug’s MAX effect; =EC50 |
|
Spare R |
receptors that do not have
to bind drug in order for max effect to be produced; Kd>ED50 |
4.
Drug efficacy and potency on dose-response curves:
Efficacy: asymptotic max of curve; Emax
Potency: dose at ½ max; EC50
Please
see page 11 of Lange’s Pharmacology for a picture.
5.
Pharmacogenetics:
Women
have a lower first-pass metabolism than men for EtOH. Gender differences rare.
Genetic
differences:
1.
Hydrolysis of esters: succinylcholine is metabolized by cholinesterase; mostly è very rapid (5min); 1/2500 è slow à neuromuscular paralysis for hours after a single dose.
2.
Acetylation of amines: isoniazid and procainamide è inact by N-acetylation; slow acetylators (auto
recess); 50% of caucasians and African-Americans in USA.
3.
Oxidation by p450: affects metabolism of debrisoquin, sparteine, phenformin,
dextromethorphan, metoprolol, some tricyclic antidep
6. Anesthesia:
MAC: conc of anesthetic (% of inhaled gas) è abolish specified painful stim in 50% of pts.
1/MAC
= Potency
Blood:
gas partition coefficient: the
more rapidly a drug equilibrates w/ the blood, the more quickly the drug passes
into the brain to prod anesthetic effects. Drugs w/ low blood:gas coeff (i.e. NO; MAC = 105%; fast
onset, fast recovery; low solubility in blood) equilibrate more rapidly than do drugs w/ a higher coeff (i.e.
halothane; MAC = 1%; high solubility in lipid; high potency).
Rate
of induction depends on:
1.
Blood:gas partition coeff: low coeff è fast onset
2.
Inspired gas PP:
high PP à faster induction
3.
Ventilation rate:
inc vent rate à faster induction
4.
Pulmonary blood flow: low flow à faster onset
(b/c PP rises as a faster rate)
5.
Arteriovenous conc gradient: uptake of soluble anesthetics into highly perfused tissues
may decrease gas tension in mixed venous blood. This can influence the rate of onset, since achievement of
equilibrium is dependent on the differences in anesthetic tension between
arterial and venous blood.
Different
IV agents: see p. 283 of First Aid
Toxicities: see p. 283
Malignant
hyperthermia: from any volatile
liq anesthetic (but esp w/ the interaction of halothane w/ succinylcholine in a
genetically predisposed individual); à decreased SR Ca++ uptake è seizures, ventilation impairment, hyperkalemia,
arrhythmias; tx w/ dantrolene,
oxygen, lower temp, other drugs
8.
Prevention/tx of cerebrovascular ds:
ASA: for primary prevention à never proven efficacious; used for secondary
prevention
Heparin/Warfarin: used for secondary prevention
Tissue
plasminogen activator (tPA): used
to treat acute stroke; must present w/in 3 hours of symptoms;
no evidence of hemorrhage on CT; no age exclusion;
symptoms consistent w/ stroke
Surgery
(Carotid endarterectomy): clean
out blockage
10. Vaccines: indications,
potential SE
·
Don’t give live
attenuated vaccines to immunocompromised/preg pts
·
SE of Live
attenuated: prod symptomatic
infect; transfer strain to others
·
SE of killed: toxic rxns and adverse responses
·
Pneumococcus vaccine
for: >65 yo, chronic
cardiac/pul ds, asplenic, alcoholics, AIDS, diabetes, mellitus, CSF leaks,
renal failure, organ transplant, chemotherapy; don’t necessarily need to
vaccinate all medical professionals.
·
Lyme vaccine only for
people who live in/travel to endemic areas
·
Haemophilus vaccine for 2
mo old, asplenics, others at risk.
·
Meningococcus vaccine for
outbreaks.
·
Rabies vaccine after
you’ve been bit by a rabid animals (w/ rabies Ig) or as prophylaxis if
you work w/ animals
·
Chickenpox vaccine
for: kids, HC workers, women of
child bearing age; not for old people.
·
Influenza vaccine
for: nursing home pts, pts w/
emphysema/heart ds/chronic cond/long-term aspirin use, pts >50 yo; if
nursing home outbreak, vaccinate residents, personal
·
MMR at 15 mo and school
age. Avoid during pregnancy!!!
·
DPT as immunoprophylaxis
for kids only; booster every 10 years of dT.
·
Polio (IPV; killed) for
kids and non-immune adults; don’t give OPV (live) b/c you’re more
likely to get polio from a rxn to OPV than from a natural source of polio;
boosters for people traveling to places w/ lots of polio, people taking care of
pts excreting lots of polio, people who to lab work w/ polio.
·
Hepatitis B vaccine for
kids, IV drug users, hemodialysis pts, institutionalized pts, immigrants,
prisoners, babies whose moms = +, hemophiliacs, gays, people w/ multiple sexual
partners/STDs, healthcare workers.
·
Hep A give 2-4 wks before
travel to endemic areas.
·
Typhoid: exposure from travel, epidemic, or
household contact; last 3 years.